Tag #Genetic Testing

Showing 13 to 23 of 23 results

bbc.com

🌐 85% Global Worthiness

Apr 16, 10:08

Northern Scotland's High Huntington's Disease Rate Prompts Call for Action

A new study shows Northern Scotland has a Huntington's disease rate of 14.5 per 100,000 people—over five times the global average—with over 160 adults in the region genetically predisposed but untested, prompting calls for improved care planning.

Northern Scotland's High Huntington's Disease Rate Prompts Call for Action

A new study shows Northern Scotland has a Huntington's disease rate of 14.5 per 100,000 people—over five times the global average—with over 160 adults in the region genetically predisposed but untested, prompting calls for improved care planning.

Progress

4% Bias Score

ShareSaveArticle

Good Health and Well-being

12345678

Previous 1 of 8 Next

How does this study's methodology differ from previous research, and what additional insights does it provide regarding the scope of the problem?

The study's use of family tree records, unlike previous statistical models, provides a more precise count of those at risk. This precise data is crucial for planning healthcare services and future treatments. The high rate necessitates immediate action for resource allocation and care planning.

edition.cnn.com

🌐 85% Global Worthiness

Mar 31, 10:10

23andMe Files for Bankruptcy Amid Data Privacy Concerns

23andMe, a genetic testing service with 15 million customers, filed for Chapter 11 bankruptcy on March 23, 2025, due to declining revenue and mounting losses since its 2021 IPO, prompting concerns about the privacy of user data amid a potential sale.

23andMe Files for Bankruptcy Amid Data Privacy Concerns

23andMe, a genetic testing service with 15 million customers, filed for Chapter 11 bankruptcy on March 23, 2025, due to declining revenue and mounting losses since its 2021 IPO, prompting concerns about the privacy of user data amid a potential sale.

Progress

48% Bias Score

ShareSaveArticle

Good Health and Well-being

12345678

Previous 1 of 8 Next

What are the long-term implications of 23andMe's bankruptcy for data privacy in the consumer genetic testing market?

The bankruptcy filing highlights the inherent risks and vulnerabilities of consumer genetic data. Growing privacy concerns, amplified by a recent data breach and the potential sale of the company, have prompted legal action, including calls from state attorneys general for customers to delete their data. The surge in help page visits regarding data deletion underscores these concerns and the challenging regulatory landscape facing the genetic testing industry.

forbes.com

🌐 85% Global Worthiness

Mar 26, 19:24

US Drug Overdose Deaths Fall 25%, but Medicaid Cuts Pose Threat

Fatal drug overdoses in the US declined by 25% in the year ending October 2024, with decreased fentanyl deaths leading the way; however, 82,000 overdose deaths still occurred, and proposed Medicaid cuts could reverse this trend.

US Drug Overdose Deaths Fall 25%, but Medicaid Cuts Pose Threat

Fatal drug overdoses in the US declined by 25% in the year ending October 2024, with decreased fentanyl deaths leading the way; however, 82,000 overdose deaths still occurred, and proposed Medicaid cuts could reverse this trend.

Progress

48% Bias Score

ShareSaveArticle

Good Health and Well-being

12345678

Previous 1 of 8 Next

How have policy changes and increased access to naloxone contributed to the recent decline in overdose deaths?

The decrease in overdose deaths correlates with increased access to naloxone, following FDA approval of over-the-counter formulations and a government initiative to expand training and access. However, proposed cuts to Medicaid, which covers a significant portion of overdose-related emergency care, threaten to reverse this positive trend.

elpais.com

🌐 85% Global Worthiness

Mar 25, 16:16

23andMe Declares Bankruptcy, Raising Concerns Over Genetic Data

23andMe, the pioneering genetic testing company founded by Anne Wojcicki, declared bankruptcy this week after struggling with profitability, leaving the fate of 15 million customers' genetic data uncertain.

23andMe Declares Bankruptcy, Raising Concerns Over Genetic Data

23andMe, the pioneering genetic testing company founded by Anne Wojcicki, declared bankruptcy this week after struggling with profitability, leaving the fate of 15 million customers' genetic data uncertain.

Progress

44% Bias Score

ShareSaveArticle

Good Health and Well-being

12345678

Previous 1 of 8 Next

What are the immediate consequences of 23andMe's bankruptcy for its customers and the broader genetic testing market?

23andMe, a pioneer in direct-to-consumer genetic testing, declared bankruptcy this week after failing to achieve profitability. The company, founded by Anne Wojcicki, initially valued at $3.5 billion during its 2021 IPO, lost 80% of its value last year and now faces liquidation with a valuation under $20 million. Wojcicki resigned as CEO.

dailymail.co.uk

🌐 75% Global Worthiness

Mar 13, 16:12

Sarah Beeny advocates for brain tumor research after cancer battle

Following her battle with breast cancer, broadcaster Sarah Beeny, 53, announced she is now cancer-free and a new patron of Brain Tumour Research, advocating for increased research funding after losing her mother and stepmother to brain tumors.

Sarah Beeny advocates for brain tumor research after cancer battle

Following her battle with breast cancer, broadcaster Sarah Beeny, 53, announced she is now cancer-free and a new patron of Brain Tumour Research, advocating for increased research funding after losing her mother and stepmother to brain tumors.

Progress

44% Bias Score

ShareSaveArticle

Good Health and Well-being

12345678

Previous 1 of 8 Next

What is the significance of Sarah Beeny's new charity role and public advocacy for brain tumor research?

Sarah Beeny, a 53-year-old broadcaster, has announced she is now cancer-free after a battle with breast cancer that included chemotherapy and a double mastectomy. She is now a patron of Brain Tumour Research, advocating for increased research funding. This follows her own family history of brain tumors, which claimed the lives of her mother and stepmother.

sante.lefigaro.fr

🌐 85% Global Worthiness

Mar 1, 16:10

Advocate Highlights Systemic Issues in Rare Disease Diagnosis

Following her daughter's death from a rare liver disease due to delayed diagnosis, Hélène Berrué-Gaillard advocates for earlier diagnosis and improved care for rare diseases, leading to changes in child health records and pediatric consultation schedules, and highlighting persistent systemic challen...

Advocate Highlights Systemic Issues in Rare Disease Diagnosis

Following her daughter's death from a rare liver disease due to delayed diagnosis, Hélène Berrué-Gaillard advocates for earlier diagnosis and improved care for rare diseases, leading to changes in child health records and pediatric consultation schedules, and highlighting persistent systemic challen...

Progress

44% Bias Score

ShareSaveArticle

Good Health and Well-being

12345678

Previous 1 of 8 Next

What immediate impact did Hélène Berrué-Gaillard's advocacy have on healthcare practices concerning rare diseases in children?

Hélène Berrué-Gaillard's daughter died from a rare liver disease due to a delayed diagnosis. This led her to establish an association to advocate for earlier diagnosis and improved care for children with rare diseases, resulting in changes to child health records and pediatric consultation schedules.

theguardian.com

🌐 85% Global Worthiness

Apr 4, 22:13

23andMe Bankruptcy Underscores Need for Genetic Data Privacy Reform

23andMe's bankruptcy necessitates updating the Genetic Information Non-Discrimination Act to protect consumer genetic data from misuse, given the growing use of polygenic indexes for various predictions, creating both opportunities and challenges for individuals and insurers.

23andMe Bankruptcy Underscores Need for Genetic Data Privacy Reform

23andMe's bankruptcy necessitates updating the Genetic Information Non-Discrimination Act to protect consumer genetic data from misuse, given the growing use of polygenic indexes for various predictions, creating both opportunities and challenges for individuals and insurers.

Progress

44% Bias Score

ShareSaveArticle

Good Health and Well-being

12345678

Previous 1 of 8 Next

What are the immediate implications of 23andMe's bankruptcy for consumers and the broader landscape of genetic data privacy?

23andMe's bankruptcy highlights the vulnerability of consumer genetic data and the need for stronger legal protections. The company's failure allows users to download their data, raising concerns about its potential misuse by other entities. This situation underscores the urgency of updating regulations to address the increasing use of polygenic indexes for various predictions.

cnn.com

🌐 85% Global Worthiness

Mar 30, 16:08

23andMe Files for Bankruptcy Amidst Data Breach and Financial Struggles

23andMe, a genetic testing company with 15 million customers, filed for Chapter 11 bankruptcy on March 23, 2025, due to declining revenue, a data breach, and an unsustainable business model; the company is facing calls for data deletion from concerned customers and regulators.

23andMe Files for Bankruptcy Amidst Data Breach and Financial Struggles

23andMe, a genetic testing company with 15 million customers, filed for Chapter 11 bankruptcy on March 23, 2025, due to declining revenue, a data breach, and an unsustainable business model; the company is facing calls for data deletion from concerned customers and regulators.

Progress

48% Bias Score

ShareSaveArticle

Good Health and Well-being

12345678

Previous 1 of 8 Next

How did 23andMe's business model and financial performance contribute to its current crisis?

The company's struggles stem from a lagging growth in new subscriptions and an unsustainable business model heavily reliant on direct-to-consumer sales of genetic testing kits. Despite a past collaboration with GSK and a substantial investment, 23andMe has consistently reported substantial net losses, totaling $666 million last fiscal year and $174 million in the first nine months of fiscal 2025. This financial instability, coupled with the data breach, has fueled consumer concerns and calls for data deletion.

npr.org

🌐 85% Global Worthiness

Mar 25, 19:19

23andMe Bankruptcy Raises Genetic Data Privacy Concerns

23andMe, a California-based genetic testing company with over 15 million users, filed for Chapter 11 bankruptcy this week, prompting concerns about user data privacy; however, the company maintains that customer data remains protected under existing regulations and will remain so under any future ow...

23andMe Bankruptcy Raises Genetic Data Privacy Concerns

23andMe, a California-based genetic testing company with over 15 million users, filed for Chapter 11 bankruptcy this week, prompting concerns about user data privacy; however, the company maintains that customer data remains protected under existing regulations and will remain so under any future ow...

Progress

36% Bias Score

ShareSaveArticle

12345678

Previous 1 of 8 Next

What immediate impact will 23andMe's bankruptcy filing have on the 15 million users' genetic data?

23andMe, facing financial difficulties, has filed for Chapter 11 bankruptcy, raising concerns about user data. The company assures users that their data remains protected and any buyer will be legally obligated to maintain this protection. A California Attorney General's 8-step guide allows users to delete their data from 23andMe.

aljazeera.com

🌐 75% Global Worthiness

Mar 25, 01:11

23andMe Files for Bankruptcy Amid Data Breach and Weak Demand

23andMe, a San Francisco-based genetic testing firm, filed for Chapter 11 bankruptcy protection on Sunday due to weak demand, a 2023 data breach affecting nearly seven million customers, and subsequent financial losses; co-founder and CEO Anne Wojcicki resigned to independently bid on the company's ...

23andMe Files for Bankruptcy Amid Data Breach and Weak Demand

23andMe, a San Francisco-based genetic testing firm, filed for Chapter 11 bankruptcy protection on Sunday due to weak demand, a 2023 data breach affecting nearly seven million customers, and subsequent financial losses; co-founder and CEO Anne Wojcicki resigned to independently bid on the company's ...

Progress

52% Bias Score

ShareSaveArticle

Reduced Inequality

12345678

Previous 1 of 8 Next

How did the 2023 data breach and subsequent legal action contribute to 23andMe's financial struggles?

The bankruptcy highlights challenges in the DNA testing market, with waning demand and privacy concerns contributing to 23andMe's downfall. The company's $30 million settlement for the data breach further exacerbated financial difficulties, leading to layoffs and the cessation of its therapeutics division. The market, according to Bernstein Research, may be saturated.

dailymail.co.uk

🌐 75% Global Worthiness

Mar 2, 22:12

Two Sisters Diagnosed with Aggressive Breast Cancer Within Two Weeks

Two sisters, aged 28 and 32, were diagnosed with stage two triple-negative breast cancer (TNBC) two weeks apart; both carry the BRCA1 gene and emphasize the importance of early detection and genetic testing.

Two Sisters Diagnosed with Aggressive Breast Cancer Within Two Weeks

Two sisters, aged 28 and 32, were diagnosed with stage two triple-negative breast cancer (TNBC) two weeks apart; both carry the BRCA1 gene and emphasize the importance of early detection and genetic testing.

Progress

40% Bias Score

ShareSaveArticle

Good Health and Well-being

12345678

Previous 1 of 8 Next

How did the sisters' proactive health behaviors and knowledge of their genetic predisposition contribute to their early diagnoses?

The sisters' diagnoses highlight the importance of early detection and genetic testing for BRCA1, a mutation increasing breast cancer risk. Their similar cases, despite living in different states, underscore the need for increased awareness of TNBC, especially among women under 40 who are at higher risk. The sisters' proactive health measures likely contributed to their early diagnoses, improving their chances of successful treatment.

Showing 13 to 23 of 23 results